First Program 백업 20231014

Inflammatory dying cells exacerbate inflammatory diseases
by markedly elevating CD47 expression, thereby strategically evading their removal. 

Inflammatory dying cells 

exacerbate inflammatory diseases by markedly elevating CD47 expression, 
thereby strategically evading their removal. 

SIRP-NV (SBI-102), Immunotherapy to remove the pathological cells

​SBI-102 pioneers the concept of immunotherapy, 
Awakening the body’s innate immune system to amplify its regenerative potential ​

SBI-102 can be the game changer of the CD47 blockade.

SIRP-NV demonstrates high expandability in indication, starting from a nichebuster for rare diseases and evolving into a blockbuster for intractable diseases.